149 related articles for article (PubMed ID: 37550460)
1. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
Lin J; Huang H
Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460
[TBL] [Abstract][Full Text] [Related]
2. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study.
Tan Q; Wang X; Li Y; Liu Y; Liu X; Ke N
Front Endocrinol (Lausanne); 2022; 13():907415. PubMed ID: 35873006
[TBL] [Abstract][Full Text] [Related]
4. Preoperative acute pancreatitis and hyperenzymemia are associated with poor prognosis in patients with nonfunctional pancreatic neuroendocrine tumors.
Song H; Tan Q; Yuan Y; Liu X; Chen Y; Wang X
J Surg Oncol; 2023 Jun; 127(7):1135-1142. PubMed ID: 36912877
[TBL] [Abstract][Full Text] [Related]
5. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
[TBL] [Abstract][Full Text] [Related]
7. A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes.
Powers BD; Rothermel LD; Fleming JB; Strosberg JR; Anaya DA
J Gastrointest Surg; 2020 Dec; 24(12):2773-2779. PubMed ID: 31754990
[TBL] [Abstract][Full Text] [Related]
8. Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis.
Sonbol MB; Mazza GL; Mi L; Oliver T; Starr J; Gudmundsdottir H; Cleary SP; Hobday T; Halfdanarson TR
Oncologist; 2022 Jul; 27(7):573-578. PubMed ID: 35348774
[TBL] [Abstract][Full Text] [Related]
9. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
[TBL] [Abstract][Full Text] [Related]
11. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
Chen J; Yang Y; Liu Y; Kan H
World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
[TBL] [Abstract][Full Text] [Related]
12. Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cm.
Mirkin KA; Hollenbeak CS; Wong J
J Surg Res; 2017 May; 211():206-214. PubMed ID: 28501118
[TBL] [Abstract][Full Text] [Related]
13. Impact of Surgery on Non-Functional Pancreatic Neuroendocrine Tumors ≤2 cm: Analyses With Propensity Score-Based Inverse Probability of Treatment Weighting.
Ye J; Wu H; Li J; Liu C
Front Surg; 2022; 9():890564. PubMed ID: 36071950
[TBL] [Abstract][Full Text] [Related]
14. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States.
Liu X; Chen B; Chen J; Su Z; Sun S
J Endocrinol Invest; 2023 Jul; 46(7):1373-1384. PubMed ID: 36522587
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
16. Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study.
So H; Ko SW; Shin SH; Kim EH; Son J; Ha S; Song KB; Kim HJ; Kim MH; Park DH
Gastrointest Endosc; 2023 Apr; 97(4):741-751.e1. PubMed ID: 36400239
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment.
Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W
Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis.
Mei W; Cao F; Lu J; Qu C; Fang Z; Li J; Li F
Front Endocrinol (Lausanne); 2023; 14():1140873. PubMed ID: 37020595
[TBL] [Abstract][Full Text] [Related]
19. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
Ye H; Xu HL; Shen Q; Zheng Q; Chen P
J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
[TBL] [Abstract][Full Text] [Related]
20. Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: An NCDB Analysis.
Kaslow SR; Vitiello GA; Prendergast K; Hani L; Cohen SM; Wolfgang C; Berman RS; Lee AY; Correa-Gallego C
Ann Surg Oncol; 2022 Jun; 29(6):3522-3531. PubMed ID: 35246811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]